Index rose to 7,460 points before falling back
Daniel Koller, BB Biotech's head of investment, discusses sector growth, innovation and the attractive valuations of fast-growing companies.
Brent crude fell 10% last week
Be prepared to actively trade
Currency gains added to performance
Aiming to achieve 4% per annum
Becoming the Creation Portfolios
ETPs attracting record flows
The traditional 60/40 fund, which dates back to the 1950s, no longer works in the current economic climate, argues Ashley Lynn, analyst at Orbis Investments.